4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-24-003330
COO,Chief Scientist & Chairman sold 131,386 shares at an average $54.59 ($7,171,768)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-10 | Sale 10b5-1 | −78,236 | $54.32 | $4,249,967 | 1,157,566 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-10 | Sale 10b5-1 | −50,514 | $54.89 | $2,772,506 | 1,107,052 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-10 | Sale 10b5-1 | −920 | $55.95 | $51,477 | 1,106,132 | D |
| Luo Mary Z. COO,Chief Scientist & Chairman | 2024-01-10 | Sale 10b5-1 | −1,716 | $57.00 | $97,817 | 1,104,416 | D |
| Open-market sales · 131,386 sh · avg $54.59 · $7,171,768 | |||||||
Loading xslF345X05/tm241836-3_4seq1.xml…